Earnings call InMode revises 2024 guidance amid sales, operational challenges
| 49327M3E2 | 99.05 0.36 0.36% |
About 61% of 49327M3E2's investor base is looking to short. The analysis of the overall prospects from investing in KEY 415 08 AUG 25 suggests that many traders are, at the present time, alarmed. The current market sentiment, together with 49327M3E2's historical and current headlines, can help investors time the market. In addition, many technical investors use KEY 415 08 bond news signals to limit their universe of possible portfolio assets.
49327M3E2 |
Earnings call InMode revises 2024 guidance amid sales, operational challenges
Read at investing.com
 |
KEY 415 08 Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with 49327M3E2 bond to make a market-neutral strategy. Peer analysis of 49327M3E2 could also be used in its relative valuation, which is a method of valuing 49327M3E2 by comparing valuation metrics with similar companies.
Peers
49327M3E2 Related Equities
| MBOT | Microbot Medical | 11.00 | ||||
| XTNT | Xtant Medical | 6.98 | ||||
| AMGN | Amgen | 0.20 | ||||
| ARM | Arm Holdings | 0.38 | ||||
| ENTG | Entegris | 0.45 | ||||
| AVDL | Avadel Pharmaceuticals | 0.66 | ||||
| MX | MagnaChip Semiconductor | 1.19 | ||||
| TER | Teradyne | 1.76 |
Other Information on Investing in 49327M3E2 Bond
49327M3E2 financial ratios help investors to determine whether 49327M3E2 Bond is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in 49327M3E2 with respect to the benefits of owning 49327M3E2 security.